Area of research
Epidemiology · Immunology
Research interest
Research interests include Meningioma and schwannoma management, Glioma Diagnosis and Treatment, Immune cells in cancer, and Neurofibromatosis and Schwannoma Cases.
Chromosome 1p Loss and 1q Gain for Grading of Meningioma
Molecular signatures define <i>BAP1</i>-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
Outcome-associated factors in a molecularly defined cohort of central neurocytoma
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Development and validation of a molecular classifier of meningiomas
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival
VGLL fusions define a new class of intraparenchymal central nervous system schwannoma
Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13, 466
Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
The prognostic role of the immunohistochemical expression of S100 in meningiomas
Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort
Increased proliferation is associated with CNS invasion in meningiomas
A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials
Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging
COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma
Epigenome-wide data collection in a case of gliofibroma
Mib1 Expression Is Increased in Meningiomas with Histopathological Evidence of Cns Invasion
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
CNS Invasion in Meningioma—How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence